Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One thousand patients with essential thrombocythemia: the Mayo Clinic experience
Naseema Gangat, Omer Karrar, Aref Al‐Kali, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 37
Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification
Jürgen Thiele, H. M. Kvasnicka, Umberto Gianelli, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial
Bianca Rocca, Alberto Tosetto, Giovanna Petrucci, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1462-1474
Open Access | Times Cited: 7
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2‐ and CALR‐mutated essential thrombocythemia—A Mayo Clinic study of 200 pregnancies
Naseema Gangat, Amritpal Singh, Rimal Ilyas, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 10, pp. 1862-1869
Closed Access | Times Cited: 4
Essential Thrombocythemia
Ayalew Tefferi, Naseema Gangat, Giuseppe Gaetano Loscocco, et al.
JAMA (2025)
Closed Access
CALR—mutant myeloproliferative neoplasms: insights from next-generation sequencing
Aleksandra Mroczkowska-Bękarciak, Agnieszka Szeremet, Olga Chyrko, et al.
Journal of Applied Genetics (2025)
Open Access
CALR -mutated myeloproliferative neoplasms
Valentina Bellani, Barbara Mora, Alessandra Iurlo, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-13
Closed Access
[Advances in the diagnosis and treatment of thrombocytosis in children].
Yuting Xu, Qun Hu
PubMed (2025) Vol. 27, Iss. 2, pp. 236-241
Closed Access
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis
Marko Lucijanić, Ivan Krečak, Davor Galušić, et al.
Annals of Hematology (2024) Vol. 103, Iss. 6, pp. 2157-2159
Closed Access | Times Cited: 3
Treatment‐associated decline inJAK2V617F allele burden in polycythemia vera: What does it mean?
Ayalew Tefferi, Animesh Pardanani, Naseema Gangat
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1459-1461
Closed Access | Times Cited: 2
Are thrombosis, progression, and survival in ET predictable?
Ghaith Abu‐Zeinah, Katie Erdos, Neville Lee, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Prediction models for essential thrombocythemia from two longitudinal studies involving 2000 patients
Tiziano Barbui, Alessandra Carobbio
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Aspirin use in essential thrombocythemia: Once‐daily or twice‐daily or not at all?
Ayalew Tefferi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 8, pp. 1450-1453
Closed Access
Clinical utility of investigations in triple‐negative thrombocytosis: A real‐world, multicentre evaluation of UK practice
Anna L. Godfrey, Nikolaos Sousos, Rebecca Frewin, et al.
British Journal of Haematology (2024)
Closed Access
Optimizing Outcomes of Accelerated and Blast-Phase Myeloproliferative Neoplasms
Naseema Gangat, Ayalew Tefferi
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S92-S94
Closed Access
Bleeding heralding the diagnosis of essential thrombocythemia
G. Stalder, Francesco Grandoni, Lorenzo Alberio
European Journal of Internal Medicine (2024) Vol. 123, pp. 165-166
Closed Access
Queries regarding the two papers each reporting on 1000 essential thrombocythemia patients in BCJ
Martin Ellis
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access
Page 1

Scroll to top